TABLE 2.
Animal weights, blood pressure, serum and urine parameters.
Weights, blood pressure, plasma and urine parameters | Sham | 2K1C + placebo | 2K1C + ICA |
---|---|---|---|
Body weight [g] | 388.6 ± 11.2 | 292.4 ± 11.7* | 284.9 ± 10.8* |
Rel. right kidney weight [mg/g] | 3.15 ± 0.07 | 5.56 ± 0.33* | 5.30 ± 0.25* |
Rel. left kidney weight [mg/g] | 3.11 ± 0.08 | 3.82 ± 0.16* | 4.02 ± 0.21* |
Rel. left ventricular weight [mg/g] | 2.20 ± 0.04 | 3.92 ± 0.15* | 3.91 ± 0.11* |
MAP intra-arterial [mm Hg] | 128.3 ± 9.2 | 221.1 ± 6.4* | 212.3 ± 7.7* |
BP tail cuff [mm Hg] | 95.6 ± 5.5 | 208.3 ± 6.7* | 196.7 ± 8.9* |
Serum aldosterone [ng/ml] | 441.0 ± 64.7 | 3,133.4 ± 561.4* | 2943.6 ± 465.6* |
Serum creatinine [mg/dl] | 0.20 ± 0.03 | 0.26 ± 0.03 | 0.48 ± 0.14* |
Serum urea [mg/dl] | 30.16 ± 3.39 | 60.05 ± 6.34 | 100.45 ± 19.55 * § |
Albuminuria [mg/g creatinine] | 0.046 ± 0.002 | 12.51 ± 2.91* | 12.06 ± 3.61* |
*, p < 0.05 versus sham; §, p < 0.05 versus 2K1C + placebo (ANOVA, followed by Fisher’s Least Significant Differences post-hoc test); N = 8–9, sham; n = 15–18, 2K1C + placebo; n = 12–15, 2K1C + ICA., sham, control sham operation; 2K1C, 2-kidney-1-clip hypertensive rats; ICA, 2-(1-chloro-4- hydroxyisoquinoline- 3-carboxamido) acetate; MAP, mean arterial blood pressure; BP, blood pressure.